CCNYL5

Across TCGA pan-cancer cohorts, CCNYL5 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of CCNYL5’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where CCNYL5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CCNYL5 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

LUAD, KICH, and LUSC are the cancer types where CCNYL5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCNYL5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	II,III,IV	+0.113	.019	2	view →
KICH	All	All	−0.021	.019	2	view →
LUSC	Male	All	+0.040	.045	1	view →
KIRC	All	IV	+0.019	.024	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

CCNYL5–LUAD

Open the LUAD breakdown →